Judge Sanctions Roxane In Asacol Patent Suit

Law360, New York (January 31, 2011, 8:11 PM EST) -- A federal judge has ruled that Roxane Laboratories Inc. must pay some of the expert and attorneys' fees for the plaintiffs in a patent dispute over inflammatory bowel drug Asacol as punishment for concealing a batch of its generic version.

Magistrate Judge Tonianne Bongiovanni of the U.S. District Court for the District of New Jersey on Friday granted a motion by Medeva Pharma Suisse AG and Warner Chilcott Pharmaceuticals Inc. to impose sanctions for Roxane's concealment, but denied the plaintiffs' motion to impose sanctions for Roxane's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.